Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             123 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 1A.1 Animal model of fetal loss in factor V Leiden carriers: pathogenic mechanism and therapeutic targets Sood, R.
 2007
 119 S1 p. S1-S2
2 p.
 artikel
2 7A.1 Bleeding in the neonate Kenet, G.
 2007
 119 S1 p. S82-S84
3 p.
 artikel
3 42 Absence of the transcription factor NFE2 impairs placental labyrinthine layer development during late midgestation Kashif, M.
 2007
 119 S1 p. S108-
1 p.
 artikel
4 67 A comparison of the PK/PD of tinzaparin in pregnant women and in non-pregnant healthy volunteers Smith, M.P.
 2007
 119 S1 p. S115-
1 p.
 artikel
5 33 A database of inherited causes of thrombophilia in a region of Southern Italy Grandone, E.
 2007
 119 S1 p. S106-
1 p.
 artikel
6 6A.4 Debate: Antithrombotics for prevention of pregnancy loss – No Middeldorp, S.
 2007
 119 S1 p. S76-
1 p.
 artikel
7 6A.3 Debate: Antithrombotics for prevention of pregnancy loss – Yes Brenner, B.
 2007
 119 S1 p. S74-S75
2 p.
 artikel
8 1A.3 Development of hemostasis in the fetus and neonate Manco-Johnson, M.J.
 2007
 119 S1 p. S4-S5
2 p.
 artikel
9 3A.2 Fetal prothrombotic genetic risk factors and fetal acquired risk factors for adverse perinatal outcome Dekker, G.
 2007
 119 S1 p. S26-S27
2 p.
 artikel
10 6A.1 Fibrin formation disorders and pregnancy loss Muszbek, L.
 2007
 119 S1 p. S69-S70
2 p.
 artikel
11 2A.1 Haemostasis in pre-eclampsia Higgins, J.R.
 2007
 119 S1 p. S14-S15
2 p.
 artikel
12 1A.2 Hemostasis in normal pregnancy Eichinger, S.
 2007
 119 S1 p. S3-
1 p.
 artikel
13 4A.2 HIT update: new tests, old tests, useful tests? Greinacher, A.
 2007
 119 S1 p. S39-S40
2 p.
 artikel
14 6A.2 Inherited thrombophilia and pregnancy loss Gris, J.-C.
 2007
 119 S1 p. S71-S73
3 p.
 artikel
15 3A.3 Management of thrombophilia in women with placental vascular complications Kupferminc, M.J.
 2007
 119 S1 p. S28-S29
2 p.
 artikel
16 7A.3 Neonatal alloimmune thrombocytopenia: Where do we stand? Kaplan, C.
 2007
 119 S1 p. S88-S89
2 p.
 artikel
17 66 Anticoagulant treatment in a hypercoagulable woman with mechanical prosthetic mitral valve – failure of high-dose low molecular weight heparin (LMWH) treatment Sandset, P.M.
 2007
 119 S1 p. S115-
1 p.
 artikel
18 18 Anticoagulation of mechanical valves in pregnancy: potential role for thromboelastography and thrombin generation – a case report Chowdary, P.
 2007
 119 S1 p. S101-S102
2 p.
 artikel
19 7 Antiphospholipid antibodies spectrum in patients with the history of fetal loss syndrome and in their children Baimuradova, S.M.
 2007
 119 S1 p. S99-
1 p.
 artikel
20 2A.2 Pathogenesis and treatment of disseminated intravascular coagulation (DIC) in the peri-partum period Levi, M.
 2007
 119 S1 p. S16-
1 p.
 artikel
21 5A.3 Placental TF-TFPI balance Aharon, A.
 2007
 119 S1 p. S60-S61
2 p.
 artikel
22 2A.3 Post-partum hemorrhage McLintock, C.
 2007
 119 S1 p. S17-S18
2 p.
 artikel
23 14 A red blood cell agglutination D-dimer test for the diagnosis of DVT in pregnancy: a prospective cohort study Chan, W.-S.
 2007
 119 S1 p. S100-S101
2 p.
 artikel
24 15 Assessment of puerperial blood loss (lochia) in women with inherited bleeding disorders Chi, C.
 2007
 119 S1 p. S101-
1 p.
 artikel
25 1A.4 The protein C anticoagulant pathway: new insights Lane, D.A.
 2007
 119 S1 p. S6-S7
2 p.
 artikel
26 5A.2 The role of platelets during reproduction Isermann, B.
 2007
 119 S1 p. S58-S59
2 p.
 artikel
27 4A.1 Thrombocytopenia in pregnancy D'Angelo, A.
 2007
 119 S1 p. S37-S38
2 p.
 artikel
28 7A.2 Thrombosis in the neonate Nowak-Göttl, U.
 2007
 119 S1 p. S85-S87
3 p.
 artikel
29 4A.3 Thrombotic thrombocytopenic purpura Varon, D.
 2007
 119 S1 p. S41-S42
2 p.
 artikel
30 Author index, 2nd International Symposium on Women's Health Issues in Thrombosis and Haemostasis, February 2–4, 2007, Vienna, Austria 2007
 119 S1 p. S119-S121
3 p.
 artikel
31 3A.1 Vascular pathology in preeclampsia Myatt, L.
 2007
 119 S1 p. S24-S25
2 p.
 artikel
32 5A.1 When killers become builders: The role of NK cells in human placental development Yagel, S.
 2007
 119 S1 p. S55-S57
3 p.
 artikel
33 7B.2 Antiphospholipid syndrome: clinical manifestations and treatment Greaves, M.
 2007
 119 S1 p. S92-S93
2 p.
 artikel
34 3B.2 Cancer and thrombosis in women: mechanisms Falanga, A.
 2007
 119 S1 p. S33-S35
3 p.
 artikel
35 5B.3 Counseling of women with thrombophilia Konkle, B.A.
 2007
 119 S1 p. S67-S68
2 p.
 artikel
36 3B.1 Epidemiology of cancer and thrombosis in women – findings from the RIETE Registry Monreal, M.
 2007
 119 S1 p. S30-S32
3 p.
 artikel
37 5B.1 Epidemiology of hormonal therapy related thrombosis Helmerhorst, F.M.
 2007
 119 S1 p. S62-S63
2 p.
 artikel
38 2B.1 Hyperstimulation syndrome and thrombosis Conard, J.
 2007
 119 S1 p. S19-
1 p.
 artikel
39 2B.2 Infertility and thrombophilia Martinelli, I.
 2007
 119 S1 p. S20-S21
2 p.
 artikel
40 4B.1 Inflammatory and haemostatic markers in ischemic stroke Tanne, D.
 2007
 119 S1 p. S43-S44
2 p.
 artikel
41 16 Bleeding score as a screening tool for the identification and assessment of von Willebrand disease in women Chi, C.
 2007
 119 S1 p. S101-
1 p.
 artikel
42 7B.3 Management of antiphospholipid syndrome in pregnancy Carp, H.J.A.
 2007
 119 S1 p. S94-S95
2 p.
 artikel
43 4B.3 Management of valvular heart disease in pregnancy James, A.H.
 2007
 119 S1 p. S47-S49
3 p.
 artikel
44 1B.3 Management of venous thromboembolism (VTE) in pregnancy Jacobsen, A.F.
 2007
 119 S1 p. S12-S13
2 p.
 artikel
45 5B.2 Mechanism of hormonal therapy related thrombosis Tchaikovski, S.
 2007
 119 S1 p. S64-S66
3 p.
 artikel
46 6B.1 Menorrhagia and von Willebrand disease Kouides, P.A.
 2007
 119 S1 p. S77-S79
3 p.
 artikel
47 2B.3 Multiple pregnancy as a thrombin-generating event Blickstein, I.
 2007
 119 S1 p. S22-S23
2 p.
 artikel
48 4B.4 New anticoagulants Bates, S.M.
 2007
 119 S1 p. S50-S54
5 p.
 artikel
49 7B.1 Pathogenesis of the antiphospholipid syndrome (APS) Rand, J.H.
 2007
 119 S1 p. S90-S91
2 p.
 artikel
50 6B.2 Platelet function defects Cattaneo, M.
 2007
 119 S1 p. S80-S81
2 p.
 artikel
51 3B.3 Prevention and treatment of cancer associated thrombosis Kakkar, A.K.
 2007
 119 S1 p. S36-
1 p.
 artikel
52 1B.1 Risk factors and diagnosis of VTE in pregancy Greer, I.A.
 2007
 119 S1 p. S8-
1 p.
 artikel
53 4B.2 Thrombophilia and arterial thrombosis Simioni, P.
 2007
 119 S1 p. S45-S46
2 p.
 artikel
54 1B.2 Thrombophilia and gestational venous thromboembolism Zotz, R.B.
 2007
 119 S1 p. S9-S11
3 p.
 artikel
55 1 Cerebral veins thrombosis in oral contraceptive (OCP) users Procházka, M.
 2007
 119 S1 p. S97-
1 p.
 artikel
56 46 Clinical features and treatment outcomes of infants with immune thrombocytopenic purpura Rafsanjani, Kh. Arjmandi
 2007
 119 S1 p. S109-
1 p.
 artikel
57 70 Clinical management using low-molecular-weight heparin (LMWH) in pregnant women with thrombophilia, thromboembolic disease (DVT) or thrombophilia-related maternoplacental syndrome: experience in one center Villa, J.
 2007
 119 S1 p. S116-
1 p.
 artikel
58 55 Coagulation profile according to gestational age in pregnant Nigerian women Olomu, S.A.
 2007
 119 S1 p. S112-
1 p.
 artikel
59 50 Combination of von Willebrand's disease with genetic forms of thrombophilia in patients with fetal loss syndrome Makatsariya, A.D.
 2007
 119 S1 p. S110-S111
2 p.
 artikel
60 74 Computational medicine in women's health: improved prediction of pregnancies at risk using new statistical models in parameter evaluation Zotz, R.B.
 2007
 119 S1 p. S117-
1 p.
 artikel
61 38 Development of a procoagulant pattern during pregnancy among women with familial hypercholesterolemia Iversen, P.O.
 2007
 119 S1 p. S107-
1 p.
 artikel
62 37 Difference of aortic stiffness severity between male and female Hsu, C.-H.
 2007
 119 S1 p. S107-
1 p.
 artikel
63 27 Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis Eilertsen, A.L.
 2007
 119 S1 p. S104-
1 p.
 artikel
64 30 Differential effects of conventional and low dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system Eilertsen, A.L.
 2007
 119 S1 p. S105-
1 p.
 artikel
65 28 Differential effects of hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method Eilertsen, A.L.
 2007
 119 S1 p. S104-
1 p.
 artikel
66 Editorial board 2007
 119 S1 p. i-
1 p.
 artikel
67 45 Effect of fibrin matrices on increased proliferation and spreading of pre-term trophoblasts and placental villi modulation of coagulation and angiogenesis functions Lanir, N.
 2007
 119 S1 p. S109-
1 p.
 artikel
68 54 Effect of smoking during pregnancy in haemostasis of healthy neonates Mitsiakos, G.
 2007
 119 S1 p. S111-S112
2 p.
 artikel
69 4 Efficacy and safety of once-daily therapeutic dose low molecular weight heparin (tinzaparin sodium) in high-risk pregnancy ní Áinle, F.
 2007
 119 S1 p. S98-
1 p.
 artikel
70 10 Elevated factor XIII level represents an increased risk of myocardial infarction in women Bereczky, Z.
 2007
 119 S1 p. S99-S100
2 p.
 artikel
71 13 Elevated lipoprotein (a) [Lp(a)] levels: a biological marker of venous thromboembolic risk frequently found in young females Casals, F.
 2007
 119 S1 p. S100-
1 p.
 artikel
72 71 Endogenous thrombin potential and pregnancy Weiss, E.
 2007
 119 S1 p. S116-S117
2 p.
 artikel
73 34 Enoxaparin and low dose aspirin in antiphospholipid syndrome (APS) associated with recurrent pregnancy loss (RPL) Herrada, J.
 2007
 119 S1 p. S106-
1 p.
 artikel
74 68 Evaluation of plasmatic global hypercoagulable assays during normal and LMWH treated pregnancies Sarig, G.
 2007
 119 S1 p. S115-S116
2 p.
 artikel
75 41 Evaluation of the hyperlipidemia and hyperglycemia in progesterone only pill (POP) users Kashanian, M.
 2007
 119 S1 p. S108-
1 p.
 artikel
76 11 Evaluation of the preconception treatment in prevention of recurrent preeclampsia Bitsadze, V.O.
 2007
 119 S1 p. S100-
1 p.
 artikel
77 60 Haematology Obstetric Group – a multidisciplinary approach to management in a district general hospital Penny, J.
 2007
 119 S1 p. S113-
1 p.
 artikel
78 12 Haemostatic activation in post-menopausal women taking low dose hormone therapy: less effect with transdermal administration? Brosnan, J.F.
 2007
 119 S1 p. S100-
1 p.
 artikel
79 75 High incidence of coagulation disorders may justify the routine coagulation screening in women with menorrhagia Simic, S.
 2007
 119 S1 p. S117-S118
2 p.
 artikel
80 39 Incidence and risk factors of ante- and post-natal venous thromboembolism in pregnancy (VIP study) Jacobsen, A.F.
 2007
 119 S1 p. S107-
1 p.
 artikel
81 19 Inherited prothrombotic risk factors in children with perinatal arterial stroke Coen Herak, D.
 2007
 119 S1 p. S102-
1 p.
 artikel
82 32 Inherited thrombophilia and adverse pregnancy outcome Grand, B.
 2007
 119 S1 p. S105-
1 p.
 artikel
83 20 Inherited thrombophilia: treatment during pregnancy De Carolis, S.
 2007
 119 S1 p. S102-
1 p.
 artikel
84 17 Levonorgestrel-releasing intrauterine system for the management of menorrhagia in women with inherited bleeding disorders: Long term follow-up Chi, C.
 2007
 119 S1 p. S101-
1 p.
 artikel
85 57 LMWH safety and efficacy assessment in pregnant with recurrent fetal loss syndrome Papaioannou, G.
 2007
 119 S1 p. S112-
1 p.
 artikel
86 6 Low molecular weight heparin (LMWH) and pregnancy Andersen, A.S.
 2007
 119 S1 p. S98-S99
2 p.
 artikel
87 36 Mechanical prosthetic heart valves and pregnancy: prophylaxis with dose adjusted LMW heparin in 12 pregnancies Abildgaard, U.
 2007
 119 S1 p. S106-S107
2 p.
 artikel
88 3 Microparticles have procoagulant and apoptotic effects on endothelial cells Aharon, A.
 2007
 119 S1 p. S98-
1 p.
 artikel
89 53 Obstetric and maternal complications and management of pregnant women with essential thrombocythemia or polycythemia vera Michiels, J.J.
 2007
 119 S1 p. S111-
1 p.
 artikel
90 56 Oral contraceptive associated thromboembolism. Retrospective analysis of 42 cases – long term follow up Papadakis, E.
 2007
 119 S1 p. S112-
1 p.
 artikel
91 77 Oral or vaginal administration of ethinyl estradiol has a similar impact on liver proteins and coagulation markers: results of a randomized, cross-over study Sitruk-Ware, R.
 2007
 119 S1 p. S118-
1 p.
 artikel
92 26 Pregnancy and severe thrombophilia: 35 pregnancies in hereditary antithrombin deficient women in Norway Dybedal, I.
 2007
 119 S1 p. S104-
1 p.
 artikel
93 29 Pregnancy morbidity, tissue factor pathway inhibitor deficiency and resistance to activated protein C Gardiner, C.
 2007
 119 S1 p. S104-S105
2 p.
 artikel
94 8 Prevalence of bleeding disorders in neonatal in 1994–2004 in Iran Ansari, S.
 2007
 119 S1 p. S99-
1 p.
 artikel
95 51 Prevention of recurrent pregnancy complications in patients with thrombophilia Makatsariya, A.D.
 2007
 119 S1 p. S111-
1 p.
 artikel
96 59 Protein Z in patients with pregnancy complications Papaioannou, G.
 2007
 119 S1 p. S113-
1 p.
 artikel
97 64 Protein Z in pregnancies complicated by intrauterine growth retardation Quack Loetscher, K.C.
 2007
 119 S1 p. S114-
1 p.
 artikel
98 69 Rapid activation of haemostasis after hormonal emergency contraception Van Rooijen, M.
 2007
 119 S1 p. S116-
1 p.
 artikel
99 24 Recombinant FVIIa requires fibrinogen to be efficient in severe obstetric haemorrhage – case report Ducloy-Bouthors, A.S.
 2007
 119 S1 p. S103-
1 p.
 artikel
100 65 Retrievable Günter Tulip Vena Cava Filter in prevention of pulmonary embolism in patients indicated to obstetric operation Procházka, M.
 2007
 119 S1 p. S114-S115
2 p.
 artikel
101 40 Risk association between estrogen containing oral contraceptives/hormonal therapy and pregnancy on atypical venous thromboembolism Kalsi, H.
 2007
 119 S1 p. S107-S108
2 p.
 artikel
102 52 Risk determinants of arterial thrombosis increase the risk of intrauterine growth restriction (IGR) Zotz, R.B.
 2007
 119 S1 p. S111-
1 p.
 artikel
103 44 Risk of recurrence after a first venous thromboembolic event in young women Laczkovics, C.
 2007
 119 S1 p. S109-
1 p.
 artikel
104 25 ROTEM® normal values at the end of pregnancy and immediate post-partum period Ducloy-Bouthors, A.S.
 2007
 119 S1 p. S103-
1 p.
 artikel
105 43 Safety and efficacy of tinzaparin administration during pregnancy Kotsi, P.
 2007
 119 S1 p. S108-S109
2 p.
 artikel
106 22 The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage de Prost, D.
 2007
 119 S1 p. S102-S103
2 p.
 artikel
107 2 The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia: a randomized trial Abou-Nassar, K.
 2007
 119 S1 p. S97-
1 p.
 artikel
108 48 The EPCR Ser219Gly polymorphism is associated with the risk of unexplained foetal death in couples in the NOHA First matched case-control study Lissalde-Lavigne, G.
 2007
 119 S1 p. S110-
1 p.
 artikel
109 63 The pathogenetic role of thrombophilia in women with polycystic ovary syndrome and metabolic syndrome Pshenichnikova, T.B.
 2007
 119 S1 p. S114-
1 p.
 artikel
110 47 The relation between venous thromboembolism and lifestyle factors – a report from the large prospective MISS study Lindqvist, P.G.
 2007
 119 S1 p. S110-
1 p.
 artikel
111 62 The relationship between levels of circulating microparticles, complications of pregnancy and resistance of blood flow in the feto-maternal circulation Salomon, O.
 2007
 119 S1 p. S114-
1 p.
 artikel
112 49 The role of pregestational management and use of low molecular weight heparin in patients with fetal loss syndrome Makatsariya, A.D.
 2007
 119 S1 p. S110-
1 p.
 artikel
113 58 The use of recombinant factor VIIa in life-threatening neonatal bleeding Papaioannou, G.
 2007
 119 S1 p. S113-
1 p.
 artikel
114 31 Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss; a retrospective study Folkeringa, N.
 2007
 119 S1 p. S105-
1 p.
 artikel
115 72 Thrombohemorrhagic complications during pregnancy and delivery in patients with hereditary connective tissue disorders Yudaeva, L.S.
 2007
 119 S1 p. S117-
1 p.
 artikel
116 5 Thrombophilia and prosthetic valve thrombosis in pregnancy – study of 7 cases Akinshina, S.V.
 2007
 119 S1 p. S98-
1 p.
 artikel
117 61 Thrombophilia as the most important pathogenetic factor of obstetric complications in patients with metabolic syndrome Perederyeva, E.B.
 2007
 119 S1 p. S113-S114
2 p.
 artikel
118 23 Thrombophilic patterns of coagulation factors in lupus Dhar, J.P.
 2007
 119 S1 p. S103-
1 p.
 artikel
119 73 Timing of prophylaxis with aspirin and low molecular weight heparin in pregnant women with primary antiphospholipid syndrome and recurrent miscarriages Hatzis, T.
 2007
 119 S1 p. S117-
1 p.
 artikel
120 35 Tumor endothelial marker 1 (TEM1, endosialin) is expressed in functional and morphological distinct trophoblast cells in human and mouse placenta Herzog, S.U.E.
 2007
 119 S1 p. S106-
1 p.
 artikel
121 9 Upper extremity thrombosis (UEDVT) following artificial reproductive technology (ART) can be explained by high peritoneal and lymphatic estrogen levels Bauersachs, R.M.
 2007
 119 S1 p. S99-
1 p.
 artikel
122 21 Uterine artery velocity waveforms as predictors of pregnancy outcome in patients with antiphospholipid syndrome (APS) De Carolis, S.
 2007
 119 S1 p. S102-
1 p.
 artikel
123 76 Venous thrombosis under oral contraceptives: impact of risk factors Conard, J.
 2007
 119 S1 p. S118-
1 p.
 artikel
                             123 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland